Blog

Selling a medical billing business involves more than just finding any buyer; it’s about identifying the right buyer who sees value in what your company offers. Here’s an in-depth look at who buys medical billing businesses and what they are looking for.

January 2024 Chicago, Illinois, January 17 , 2024 R1 RCM Inc. (NASDAQ: RCM), based in Murray, Utah, has completed its acquisition of Acclara from Providence. This strategic move, valued at $675 million, includes both cash and a warrant for up to 12.2 million shares of R1 stock.

With the changing economy and new regulations, an increasing share of RCM companies are exploring potential mergers and acquisitions in 2023.

As the landscape of bankruptcy continues to shift, the data are pointing to the possiblity of economic uncertainty. Data collected by Epiq Bankruptcy reveals a significant increase in bankruptcy filings in the commercial market, with implications for investors and buyers alike. In this blog, we’ll analyze the data, uncover the reasons for the surge, and offer predictions

A recently released study concludes that the healthcare revenue cycle management industry is poised for continued growth over the next decade. Specifically, it finds that the industry, which represents approximately $12.5 billion in revenue annually, is expected to grow at 12% CAGR.

This year is shaping up to be a busy season for mergers and acquisitions in the revenue cycle management (“RCM”) space.  With this in mind, we’ve rated this year’s reported transactions and have identified the top acquisitions, by month, for YTD 2023.

The total deal value of closed mergers and acquisitions worldwide declined 36% year over year during 2022, according to S&P Global. This marked a rapid retreat from the record high M&A levels experienced during 2021, when total deal values exceeded $1 trillion each quarter.